Yescarta (axicabtagene ciloleucel)

pCPA File Number: 22494

Negotiation Status:

Concluded with an LOI

Indication(s):

Follicular lymphoma (FL), Relapsed or refractory, grade 1, 2 or 3a, in adult patients after two or more lines of systemic therapy

Sponsor/Manufacturer:

Gilead Sciences Canada Inc.

CDA-AMC Project Number:

PG0314-000

pCPA Engagement Letter Issued:

2024-02-14

Negotiation Process Concluded:

2024-09-06